4//SEC Filing
Sundaram Senthil Vel 4
Accession 0001567619-22-002011
CIK 0001831363other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:00 PM ET
Size
5.6 KB
Accession
0001567619-22-002011
Insider Transaction Report
Form 4
Sundaram Senthil Vel
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-26+280,000→ 280,000 totalExercise: $5.36Exp: 2032-01-26→ Common Stock (280,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001762316
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 9:00 PM ET
- Size
- 5.6 KB